Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices

AUTOR(ES)

De Mello, Ramon Andrade, Araújo, António

FONTE

Clinics

DATA DE PUBLICAÇÃO

2012-11

RESUMO

Documentos Relacionados

• Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives
• Advanced non-small cell lung cancer – treatment with Pembrolizumab
• Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy
• Targeted therapies in non-small cell lung cancer
• Molecular characteristics of non-small cell lung cancer